AR113910A1 - Derivados de o-fenoxi y o-benciloxipropilamino con actividad contra el dolor - Google Patents

Derivados de o-fenoxi y o-benciloxipropilamino con actividad contra el dolor

Info

Publication number
AR113910A1
AR113910A1 ARP180103530A ARP180103530A AR113910A1 AR 113910 A1 AR113910 A1 AR 113910A1 AR P180103530 A ARP180103530 A AR P180103530A AR P180103530 A ARP180103530 A AR P180103530A AR 113910 A1 AR113910 A1 AR 113910A1
Authority
AR
Argentina
Prior art keywords
substituted
unsubstituted
hydrogen
alkynyl
alkyl
Prior art date
Application number
ARP180103530A
Other languages
English (en)
Original Assignee
Esteve Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Pharmaceuticals Sa filed Critical Esteve Pharmaceuticals Sa
Publication of AR113910A1 publication Critical patent/AR113910A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a derivados de o-fenoxi y o-benciloxipropilamino que tienen actividad farmacológica hacia la subunidad a2d, en particular la subunidad a2d-1, del canal de calcio dependiente del voltaje, a procesos de preparación de tales compuestos, a composiciones farmacéuticas que los comprenden, y a su uso en la terapia, en particular para el tratamiento del dolor. Reivindicación 1: Un compuesto de fórmula general (1), en donde X se selecciona de un enlace, -[C(RᵃRᵇ)]ₚ-, -[CH₂]ₚC(O)[CH₂]q-, -[CH₂]ₚC(O)N(Rᶻ)[CH₂]q-, -[CH₂]ₚN(Rᶻ)C(O)[CH₂]q- y -[CH₂]ₚN(Rᶻ)[CH₂]q-; Rᵃ se selecciona de hidrógeno, halógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; Rᵇ se selecciona de hidrógeno, halógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; alternativamente, Rᵃ y Rᵇ, tomados junto con el átomo de carbono al cual están unidos, pueden formar un cicloalquilo sustituido o no sustituido; Rᶻ se selecciona de hidrógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido, alquinilo C₂₋₆ sustituido o no sustituido, cicloalquilo sustituido o no sustituido, alquilcicloalquilo sustituido o no sustituido y -C(O)-alquilo C₁₋₆; p es 0, 1, 2, 3, 4 ó 5; q es 0, 1, 2, 3, 4 ó 5; Y¹ es -C(R¹⁰R¹⁰’)-; en donde R¹⁰ y R¹⁰’ se seleccionan independientemente de hidrógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; alternativamente, R¹⁰ y R¹⁰’ pueden formar, junto con el átomo de carbono al cual están unidos, un cicloalquilo sustituido o no sustituido; Y² es -C(R¹⁰’’R¹⁰’’’)-; en donde R¹⁰’’ y R¹⁰’’’ se seleccionan independientemente de hidrógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; alternativamente, R¹⁰’’ y R¹⁰’’’ pueden formar, junto con el átomo de carbono al cual están unidos, un cicloalquilo sustituido o no sustituido; n es 0 ó 1; R¹ se selecciona de -NR⁵R⁵’ y -NR⁵’C(O)R⁵; R² se selecciona de arilo sustituido o no sustituido y heterociclilo sustituido o no sustituido; R³ se selecciona de alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido, alquinilo C₂₋₆ sustituido o no sustituido, cicloalquilo sustituido o no sustituido y alquilcicloalquilo sustituido o no sustituido; R³’ se selecciona de hidrógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; R⁴ y R⁴’ se seleccionan independientemente de halógeno, -R⁴¹, -OR⁴¹, -NO₂, -NR⁴¹R⁴¹’, -NR⁴¹C(O)R⁴¹’, -NR⁴¹S(O)₂R⁴¹’, -S(O)₂NR⁴¹R⁴¹’, -NR⁴¹C(O)NR⁴¹’R⁴¹’’, -SR⁴¹, -S(O)R⁴¹, -S(O)₂R⁴¹, -CN, haloalquilo, haloalcoxi, -C(O)OR⁴¹, -C(O)NR⁴¹R⁴¹’, -OCH₂CH₂OR⁴¹, -NR⁴¹S(O)₂NR⁴¹’R⁴¹’’ y -C(CH₃)₂OR⁴¹; en donde R⁴¹, R⁴¹’ y R⁴¹’’ se seleccionan independientemente de hidrógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; R⁵ se selecciona de alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido, y alquinilo C₂₋₆ sustituido o no sustituido, cicloalquilo sustituido o no sustituido, arilo sustituido o no sustituido, heteroarilo sustituido o no sustituido, alquilcicloalquilo sustituido o no sustituido, alquilarilo sustituido o no sustituido y alquilheteroarilo sustituido o no sustituido; R⁵’ se selecciona de hidrógeno, alquilo C₁₋₆ sustituido o no sustituido, alquenilo C₂₋₆ sustituido o no sustituido y alquinilo C₂₋₆ sustituido o no sustituido; opcionalmente en forma de uno de los estereoisómeros, preferiblemente enantiómeros o diastereómeros, un racemato o en forma de una mezcla de al menos dos de los estereoisómeros, preferiblemente enantiómeros y/o diastereómeros, en cualquier proporción de mezcla, o una sal correspondiente de los mismos, o un solvato correspondiente de los mismos; los compuestos de fórmula (2) y (3) están adicionalmente excluidos.
ARP180103530A 2017-12-04 2018-12-03 Derivados de o-fenoxi y o-benciloxipropilamino con actividad contra el dolor AR113910A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382830 2017-12-04

Publications (1)

Publication Number Publication Date
AR113910A1 true AR113910A1 (es) 2020-06-24

Family

ID=60673755

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180103530A AR113910A1 (es) 2017-12-04 2018-12-03 Derivados de o-fenoxi y o-benciloxipropilamino con actividad contra el dolor

Country Status (3)

Country Link
AR (1) AR113910A1 (es)
TW (1) TW201938154A (es)
WO (1) WO2019110137A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220079938A (ko) * 2019-10-10 2022-06-14 에스테베 파마슈티칼스 에스에이 통증에 대한 다중모드 활성을 갖는 호모피페라지닐 및 호모피페리디닐 퀴나졸린-4(3h)-온 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5320825A (en) * 1991-05-01 1994-06-14 Trustees Of The University Of Pennsylvania Serotonin reuptake inhibitors for S.P.E.C.T. imaging
SG11201809799WA (en) * 2016-05-06 2018-12-28 Esteve Pharmaceuticals Sa Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions

Also Published As

Publication number Publication date
WO2019110137A1 (en) 2019-06-13
TW201938154A (zh) 2019-10-01

Similar Documents

Publication Publication Date Title
AR115993A2 (es) Composiciones de pirrolopirrol como activadores de piruvato quinasa (pkr)
AR100714A1 (es) Derivados de alquilo y arilo de compuestos de 1-oxa-4,9-diazaespiro undecano que tienen actividad multimodal contra el dolor
AR100715A1 (es) Derivados de alquilo de compuestos 1-oxa-4,9-diazaespiro undeceno que tienen actividad multimodal contra el dolor
AR100713A1 (es) Derivados de amida de compuestos de 1-oxa-4,9-diazaespiro undeceno que tienen actividad multimodal contra el dolor
AR105522A1 (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor
AR127309A2 (es) Derivados de piridazinona
AR077267A1 (es) Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
AR099640A1 (es) Derivados de pirrolopiridina o pirazolopiridina
RU2018106483A (ru) Соединения, подходящие для лечения расстройств, связанных с kit и pdgfr
AR089143A1 (es) Triazolopiridinas sustituidas con actividad inhibidora de ttk
AR083169A1 (es) Compuestos para tratar enfermedades neurodegenerativas
AR088829A1 (es) DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3
AR086828A1 (es) Compuestos heterociclicos fusionados como moduladores del canal ionico
AR089019A1 (es) Derivados modificados de 4-fenil-piridina
AR068888A1 (es) Derivados de 1, 3, 4 - tiadiazol, una composicion farmaceutica que los comprende y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de la quinesina ksp.
AR125425A1 (es) Inhibidores de proteina tirosina fosfatasa y sus metodos de uso
AR079205A1 (es) Morfolinotiazoles como moduladores alostericos positivos alfa 7
AR087915A1 (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1
AR109714A1 (es) Derivados de cromano, isocromano y dihidroisobenzofuranos como moduladores alostéricos negativos de mglur2, composiciones y su uso
AR102731A1 (es) Compuestos espiroisoquinolin-1,4-piperidínicos con actividad multimodal contra el dolor
PE20240930A1 (es) Analogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton
AR123648A1 (es) Compuestos de carbamoilpiridona tricíclicos puenteados y sus usos
AR120157A1 (es) Derivados de homopiperazinil y homopiperidinil quinazolin-4(3h)-ona que tienen actividad multimodal contra el dolor
AR122156A1 (es) DERIVADOS DE PIRAZOLO[1,5-a]PIRIMIDINA QUE TIENEN ACTIVIDAD MULTIMODAL CONTRA EL DOLOR

Legal Events

Date Code Title Description
FB Suspension of granting procedure